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Abstract

Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA mutase is
dependent on the transport of Cbl through lysosomes and its subsequent delivery to the cytosol and
mitochondria. We speculated that neuropathological conditions that impair lysosomal function (e.g., agerelated lipofuscinosis and specific neurodegenerative diseases) might impair lysosomal Cbl transport. To
address this question, an appropriate method to quantify intracellular Cbl transport in neuronal cell types and
brain tissue is required. Thus, we developed methods to measure [57Co] Cbl levels in lysosomes,
mitochondria and cytosol obtained from in vitro and in vivo sources. Human SH-SY5Y neurons or HT1080
fibroblasts were labeled with [57Co] Cbl and homogenized using a ball-bearing homogenizer, and the lysates
were separated into 10 fractions using ultracentrifugation in an OptiPrep density gradient. Lysosomes were
recovered from the top of the gradient (fractions 1-5), which were clearly separated from mitochondria
(fractions 7-9) on the basis of the expression of the marker proteins, LAMP2 and VDAC1. The isolated
lysosomes were intact based on their colocalization with acid phosphatase activity. The lysosomal and
mitochondrial fractions were free of the cytosolic markers beta-actin and methionine synthase. The relative
distribution of [57Co] Cbl in both neurons and fibroblasts was as follows: 6% in the lysosomes, 14% in the
mitochondria and 80% in the cytosol. This technique was also used to fractionate organelles from mouse
brain, where marker proteins were detected in the gradient at positions similar to those observed for the cell
lines, and the relative distribution of [57Co] Cbl was as follows: 12% in the lysosomes, 15% in the
mitochondria and 73% in the cytosol. These methods provide a useful tool for the investigation of intracellular
Cbl trafficking in a neurobiological setting.
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Abstract
Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA
mutase is dependent on its transit through lysosomes and subsequent delivery to cytosol and
mitochondria. We speculate that neuropathological conditions that impair lysosomal function
(e.g. age-related lipofuscinosis and certain neurodegenerative diseases) may impair lysosomal
Cbl transport. To study this question, an appropriate method to quantify intracellular Cbl
transport in neuronal cell types and brain tissue is required. We therefore developed methods
to measure [57Co]Cbl levels in lysosomes, mithochondria and cytosol derived from in vitro
and in vivo sources. Human SH-SY5Y neurons or HT1080 fibroblasts were labelled with
[57Co]Cbl, homogenised using a ball-bearing homogenizer, and the lysates separated into 10
fractions using ultracentrifugation on an OptiPrep density gradient. Lysosomes were
recovered at the top of the gradient (fractions 1 to 5) and were clearly separated from
mitochondria (fractions 7 to 9) based on marker proteins LAMP2 and VDAC1, respectively.
The isolated lysosomes were intact based on colocalisation with acid phosphatase activity.
The lysosomal and mitochondrial fractions were free of cytosolic markers beta-actin and
methionine synthase. The relative distribution of [57Co]Cbl in both neurons and fibroblasts
was: lysosomes 6%, mitochondria 14% and cytosol 80%. The technique was also used to
fractionate organelles from mouse brain where the marker proteins were detected in the
gradient at similar positions to the cell lines and relative distribution of [57Co]Cbl was:
lysosomes 12%, mitochondria 15% and cytosol 73%. These methods provide a useful tool for
investigating intracellular Cbl trafficking in a neurobiology setting.
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Abbreviations: AdoCbl, adenosyl cobalamin; Cbl, cobalamin, Hcy, homocysteine; LAMP2,

lysosomal-associated membrane protein 2; LER, Lysosome Enrichment Reagent; Met,
methionine; MS, methionine synthase; MeCbl, methyl Cbl; MMCM, methylmalonylcoenzyme A mutase; 5-methyl-THF, 5-methyltetrahydrofolate; THF, tetrahydrofolate;
VDAC1, voltage-dependent anion channel 1.
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1. Introduction
Cobalamin (Cbl)1 is required for erythrocyte formation and DNA synthesis, and plays a
crucial role in the maintenance of neurological function. Methyl Cbl (MeCbl) and adenosyl
Cbl (AdoCbl) are the forms that are active in human metabolism. These two forms of Cbl
differ only in the functional group attached to the Co atom at the centre of the Cbl corrin ring.
MeCbl is used to transform homocysteine (Hcy) to methionine (Met) via cytosolic
methionine synthase (MS). This reaction requires donation of a methyl group derived from
the transformation of 5-methyltetrahydrofolate (5-methyl-THF) to tetrahydrofolate (THF).
Through the action of methionine adenosyltransferase, Met is utilized in the formation of Sadenosylmethionine (SAM), a universal methyl donor for numerous substrates, including
DNA, RNA, hormones, proteins, and lipids. AdoCbl is required for the conversion of
methylmalonyl-coenzyme A (Mm-CoA) to succinyl-coenzyme A (Succ-CoA) via
mitochondrial Mm-CoA mutase (MMCM). Succ-CoA then enters the Krebs cycle, after
which it may be utilized in many pathways including conversion to succinate which may be
used as an electron donor or in the synthesis of porphyrins such as haeme.

MS and MMCM activities are reduced in human Cbl deficiency states, causing increased
tissue and plasma Hcy levels and, subsequent to the conversion of Mm-CoA to
methylmalonic acid (MMA), increased tissue and plasma MMA levels. Because of the roles
of both MS and MMCM in methylation reactions and multiple pathways related to, for
example, amino acid and lipid metabolism, the clinical Cbl deficiency phenotypes are
multifaceted (Baik and Russell, 1999). In addition to the “loss of function” caused by
impaired MS and MMCM activities, the accumulation of Hcy and MMA is neurotoxic and is
thought to contribute to neurodegeneration and loss of cognitive capacity (Kolker et al., 2000;
Morris, 2003).
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Cbl utilization is dependent on its transit through the intracellular lysosomal compartment
(Banerjee et al., 2009; Gailus et al., 2010; Zhao et al., 2011). We have recently proposed that
pathophysiological impairment of lysosomal functions that occur in various conditions such
as Alzheimer’s disease, lysosomal storage disorders and in age-related neuronal
lipofuscinosis may form a “road block” for efficient Cbl utilization in cells. We predict that
these conditions may impair the release Cbl from its carrier protein transcobalamin-II (TCII)
and inhibit the transport of lysosomal Cbl to both MS and MMCM (Zhao et al., 2011). In
addition, it is known that the acidic pH of the lysosome also influences the conversion of Cbl
from the “base-on” to “base-off” state, which refers to the interaction of the
dimethylbenzimidazole moiety of the Cbl molecule with the central Co atom (Banerjee,
2006). The Cbl base-off state is thought to be important for subsequent interactions with
cytosolic cargo proteins.

In order to accurately assess the trafficking of Cbl through the lysosomal compartment it is
necessary to establish subcellular fractionation methods that clearly separate lysosomes from
the intracellular compartments that contain MS and MMCM, i.e. the cytosol and
mitochondria, respectively. The aim of the current experiments was therefore to develop
subcellular fractionation methods whereby cells and brain tissues could be metabolically
labeled with [57Co]Cbl in order to quantify Cbl distribution between lysosomes, mitochondria
and cytosol.

2. Materials and methods

2.1. Cell culture
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Experiments were performed using human neuroblastoma cells (SH-SY5Y, ATCC #CRL2266) and human fibrosarcoma cells (HT1080, ATCC #CCL-121) obtained from the
American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in
DMEM supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, and 1%
glutamine, at 37˚C in a humidified atmosphere containing 5% CO2. Cells were grown in four
175 cm2 plastic flasks until approximately 70% confluent, when cells were incubated with
[57Co]cyanoCbl (0.025 Ci/ml; Cat. No. 06B-430002, MP Biomedicals, USA) in DMEM
with 10% human serum and 1% penicillin/streptomycin and 1% glutamine for 48 h. The cells
were then rinsed with cold (10˚C) PBS and harvested with 1% trypsin, and centrifuged at 600
g for 5 min at 4˚C. A small portion of the cells was stained with 0.5% trypan blue to
determine the number of viable cells.

2.2. Cell homogenization

A lysosome enrichment kit (Pierce, Cat #89839, USA) was applied to perform subcellular
fractionation. An 800 μl aliquot of extraction buffer Lysosome Enrichment Reagent (LER)
“A” containing 1% protease inhibitors was added to the cell pellets. The pellets were gently
re-suspended and incubated on ice for no more than 2 minutes. The cell suspension was
transferred to a ball-bearing cell homogenizer (Isobiotec, Germany) and homogenized on ice.
To check lysis efficiency, 10 μl of cell lysate was stained with 0.5% trypan blue and viewed
under a light microscope. Homogenization was continued until 95% cell membrane breakage
was achieved (typically 10 to 15 passages through the homogenizer). Next, the lysed cells
were transferred into a 2 ml microcentrifuge tube and 800 μl of LER “B” containing 1%
protease inhibitors was mixed with the lysed cells. The mixed cell lysates were centrifuged at
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600 g for 10 min at 4˚C to remove nuclei and membranous debris and the supernatant (1500
l) containing lysosomes, mitochondria and cytosol was collected.

2.3. Density gradient ultracentrifugation

To prepare a discontinuous density gradient, five gradient solutions were prepared by mixing
gradient dilution buffer (a 1:1 mixture of LER A and LER B) with the OptiPrep medium (that
is supplied as a 60% solution in H2O) as described in Table 1. The diluted OptiPrep density
gradient solutions were carefully overlayed in descending concentration order (i.e. 30%
OptiPrep solution first and then 27%, 23%, 20% and 17%) in a 7 ml ultracentrifuge tube
(Hitachi Koki, Japan). Next, the prepared 1500 μl supernatants from the cell extracts
described above were mixed with 500 μl of OptiPrep medium to make a final concentration
of 15% OptiPrep and this was overlayed on the top of the density gradient. The tube was
centrifuged at 145,000 g for 4 h at 4˚C using a Sorvall MTX 150 ultracentrifuge and a Sorvall
S50ST swinging bucket rotor (Thermo Scientific). After centrifugation, two distinct bands
appeared in the gradient solution (Fig. 1).

A total of 10 fractions of 600 μl each were carefully withdrawn from the top of the gradients
using extra long micropipette tips (Finntip 200, Thermo Scientific). The amount of [57Co]Cbl
in each fraction was measured by a Wallace Gamma Counter (PerkinElmer, Finland). Next,
each isolated fraction was mixed with 1000 μl PBS and centrifuged at 20,000 g for 30 min at
4˚C to separate lysosomes and mitochondria from cytosol. After centrifugation, the
supernatant of each fraction was collected and labeled as cytosolic fractions; while the pellets
from each fraction were mixed with 400 μl PBS and labeled as lysosomal and mitochondrial
fractions (subsequent to identification of organelle markers by western blotting as described
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below). Both the pellet and supernatant fractions were assessed for [57Co]Cbl radioactivity
and organelle markers. An overview of the procedure is illustrated in Figure 1.

2.4. Western blotting

To identify the fractions containing lysosomes, mitochondria, and cytosol, western blotting
was performed with appropriate antibodies to marker proteins; lysosome, lysosomalassociated membrane protein 2 (LAMP2, Southern Biotech); mitochondria, voltagedependent anion channel 1 (VDAC1, Abcam); cytosol, β-actin (Sigma) and methionine
synthase / 5-methyltetrahydrofolate-homocysteine methyltransferase (MS, Abnova). Briefly,
sample proteins from each fraction were separated on 12% SDS PAGE gels using a MiniProtean II system (Bio-Rad) at 150 V for 70 minutes followed by transfer at 100 V for 30
min onto 0.45 m nitrocellulose membranes using a Mini-Trans-Blot Electrophorectic
Transfer cell (Bio-Rad). The membranes were blocked in 5% (w/v) non-fat milk powder in
PBS for 1 h at 22˚C and then probed with anti-LAMP2 mouse monoclonal antibody (1:4000),
anti-VDAC1 rabbit polyclonal antibody (1:4000), anti-β-actin rabbit polyclonal antibody
(1:10000), and anti-MS goat polyclonal antibody (1:300) at 4°C for 16 h, followed by
incubation with the appropriate horseradish-peroxidase-conjugated rabbit anti-mouse
(1:4000, Dako), goat anti-rabbit (1:4000, Dako), and rabbit anti-goat (1:4000, Dako) IgG
antibodies for 1 h at 22˚C. Blots were rinsed in PBS and proteins were detected using
enhanced chemiluminescence (ECL, Amersham Biosciences). The membranes were exposed
to X-ray film (Fuji), developed, scanned and signal intensity was quantified using NIH Image
software.

2.5. Acid phosphatase assay
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During cell homogenization and ultracentrifugation, lysosome membranes are susceptible to
pressure and may be broken, thus lysosomal hydrolases may be leaked into the cytosol as a
consequence. Acid phosphatase is one of the acid hydrolases that exist in lysosomes and
therefore is a classical marker for the identification of lysosomes in subcellular fractionation
studies. The acid phosphatase assay kit (Sigma, Cat #CS0740) was applied to detect
lysosome membrane integrity in each fraction. Briefly, a substrate solution was prepared by
dissolving one 4-nitrophenyl phosphate tablet in 5 ml of citrate buffer and the solution
equilibrated at 37˚C. The standard solution was prepared by diluting 5 µl of the 10 mM
nitrophenol standard solution in 995 µl of 0.5 M NaOH. The reaction components and
samples were added to 96-well microtitre plates according to the manufacturer’s instructions
and samples analysed in triplicate. The plate was incubated for 10 min at 37˚C after which
time 200 µl of 0.5 M NaOH was added to all wells (except the standard) to stop the reaction.
Absorption was measured at 405 nm using a microtitre plate reader (Spectra Max, Bio
Strategy) and results expressed as acid phosphatase Units / ml (where 1 Unit of enzyme
activity will hydrolyse 1 mole of 4-nitrophenyl phosphate per min at pH 4.8 at 37˚C).

2.6. Animal study

To examine the subcellar distribution of [57Co]Cbl in lysosomes, mitochondria, and cytosol
derived from the brain, an in vivo study was carried out using two 12-month old male wildtype C57Bl/6J mouse. This study was approved by the University of Wollongong Animal
Ethics Committee and was carried out in accordance with EU Directive 2010/63/EU for
animal experiments. The mice were intraperitoneally injected with 4 Ci [57Co]cyanoCbl in a
volume of 0.2 ml sterile saline (0.9% w/v NaCl). The mice were weighed at time of injection

9

and again just before sacrifice. After 72 h the mice were sacrificed and the blood samples
were collected by cardiac puncture. The mice were then transcardially perfused with PBS and
the brain, liver and kidney were dissected. All organs were weighed and the amount of
[57Co]Cbl in these organs was measured using a gamma counter. In this experiment, only the
brain was used for organelle isolation. The brain was rinsed with PBS and cut into small
pieces (< 3 mm3). The procedures for homogenization and subcellular fractionation were the
same as described above for cultured cells.

2.7. Data analysis
Data are presented as mean ± SE of three independent experiments unless stated otherwise.
Note that the results for [57Co]Cbl are presented as counts per minute (cpm). The radioactive
tracer molecule [57Co]cyanoCbl was provided by the supplier in batches of 10.5 Ci in a
volume of 1 ml H2O containing 0.9% (vol/vol) benzyl alcohol. On the reference date
provided by the manufacturer, 0.1 ml from each batch of [57Co]cyanoCbl yielded 2.0 x 106
cpm. After evaporation to dryness and reconstitution in cell culture medium (or saline for i.p.
injection), the [57Co]cyanoCbl radioactivity was measured in a 0.1 ml aliquot to confirm
radioactivity before use in all experiments. For the experiments described herein, the
[57Co]cyanoCbl tracer was routinely used within 2 months of the reference date and the
radioactivity per 0.1 ml on the day of preparation for addition to cells or animals was 1.52 x
106 + 0.04 x 106 cpm (mean + SE, n = 8). The values ranged form 1.37 x 106 - 1.65 x 106 cpm
in these experiments. As an approximation, based on a specific activity for [57Co]cyanoCbl of
300 Ci / g, at the time of use in experiments 1000 cpm equates to ~ 2.4 pg of [57Co]Cbl. It
should be noted that in two months the radioactivity of 57Co has decreased by 14% and this
needs to be taken into account when comparing values.
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3. Results

3.1. Method overview

Cbl exists in three main compartments in the cell: the lysosome, mitochondria and cytosol. In
order to accurately assess Cbl transit through intracellular compartments, it is essential to
develop methods that can separate at least these three compartments into fractions in which
labeled Cbl can be unambiguously quantified. We therefore used the following steps to
achieve this: (1) cells were labeled with [57Co]Cbl; (2) cells were disrupted in a ball-bearing
homegnizer, (3) the isolated organelles were separated from cellular membrane debris and
nuclei, (4) the organelles were separated over an OptiPrep density gradient by
ultracentrifugation, (5) ten fractions were collected from the gradient, and (6) the fractions
were separated into pellet (organelle) and supernatant (cytosol) fractions. The methodological
detail for each of these steps is described in “Materials and Methods” and an overview is
illustrated in Figure 1. The purified fractions were then analysed for various organelle
markers and for [57Co] radioactivity.

3.2. Isolation of lysosomes, mitochondria and cytosol from fibroblasts

Our initial experiments focused on the HT1080 human fibroblast cell line. Western blot
analysis of the organelle fractions for LAMP2 and VDAC1 (lysosomal and mitochondrial
markers, respectively) revealed lysosomes were recovered from the top of the OptiPrep
gradient, especially in Fraction 1 (Fig. 2A). As LAMP2 was also detected at lower levels in
Fractions 2 to 5, these fractions together (Fractions 1 to 5) were considered to represent the
lysosomal content of the cells. In contrast, VDAC1 was detected in Fractions 7 to 9 and thus
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represented the mitochondrial fractions. It is noteworthy that -actin was detected at very low
levels, if at all, in the isolated organelle fractions, and MS was not detected in any of the
organelle fractions (Fig. 2A). This indicates that pure lysosomes can be separated from
mitochondria and that both organelles are essentially free of cytosolic contaminants that may
spuriously contribute to apparent organelle Cbl levels.

The cytosolic components of each of the ten OpitPrep gradient fractions were also assessed
by western blotting. Neither LAMP2 nor VDAC1 were detected in the cytosolic fractions,
whereas -actin was clearly detected in Fractions 1 to 8, with particularly high levels in
Fractions 1 to 4 (Fig. 2B). In addition, MS was detected in Fractions 1 to 3, with particularly
high levels in Fraction 2.

3.3. Isolation of lysosomes, mitochondria and cytosol from neurons
We also used the same method to purify lysosomes and mitochondria from the human SHSY5Y neuronal cell line. Similar to the results derived from our fibroblast studies, pure
lysosomal and mitochondrial preparations were recovered from Fractions 1 to 5 and from
Fractions 7 to 9, respectively (Fig. 3A). Neither -actin nor MS were detected in the
organelle fractions (Fig 3A). Assessment of the cytosolic fractions revealed there was no
contamination of cytosol with lysosomes or mitochondria, as assessed by lack of signal for
LAMP2 and VDAC1, respectively (Fig. 3B). Moreover, -actin was clearly detected in
Fractions 1 to 9, with particularly high levels in Fractions 1 to 6, whereas MS was detected in
predominantly Fractions 2 to 5 (Fig. 3B).

The methods we describe can therefore be used to isolate pure lysosomal, mitochondrial and
cytosolic preparations from fibroblasts and neurons.
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3.4. Confirmation that isolated lysosomes remain intact after purification

To confirm that the isolated lysosomes remained intact during the homogenization and
ultracentrifugation procedures, we assessed all organelle and cytosolic fractions for acid
phosphatase activity. The data indicate that acid phosphatase activity correlated with the
expression of LAMP2 in the lysosomal fractions from both fibroblasts and neurons (Fig 4A
and 4B, respectively). Furthermore, acid phosphatase activity was not detected in any of the
cytosolic fractions (Fig 4). This indicates that lysosomes remain structurally intact during the
isolation procedures and that the lysosomal membranes are not compromised. Note that the
buffers used in the acid phosphatase assay were adjusted to pH 4.8 so that even if the enzyme
was located in the cytosol (normally close to neutral pH) we would still detect its activity in
the 4-nitrophenyl phosphate hydrolysis assay.

3.5. Subcellular [57Co]cobalamin distribution in fibroblasts and neurons

Having established methods for the isolation of pure lysosomes, mitochondria and cytosol,
and shown that the lysosomes maintain their structural integrity, we next assessed the
subcellular distribution of [57Co]Cbl in the both fibroblasts and neurons subsequent to
metabolic radiolabeling.

Our pilot studies indicated that [57Co]Cbl labeling required 0.025 Ci [57Co] / ml of growth
medium for a 48 h incubation period. We observed that the use of either bovine serum or
heat-inactivated human serum substantially reduced the incorporation of [57Co]Cbl into cells
(H. Zhao and B. Garner, unpublished observations). After the 48 h labeling period, 24.2 +

13

1.3% of the radioactivity was incorporated into the fibroblasts (mean + SE, n=3).
Interestingly, under the same culture conditions only 6.9 + 1.5% of the radioactivity was
incorporated into the neurons (mean + SE, n=3). Despite the relatively low level of isotope
incorporation, this was clearly sufficient to assess [57Co]Cbl distribution in lysosomes,
mitochondria and cytosol. The data presented in Figure 5A indicate that for fibroblasts, the
relative distribution of [57Co]Cbl was: lysosomes 5.8 + 0.2%, mitochondria 14.0 + 0.7% and
cytosol 80.2 + 0.9% (all mean + SE, n=3). The corresponding data for neurons was:
lysosomes 5.1 + 0.3%, mitochondria 13.3 + 0.6% and cytosol 81.6 + 0.8% (all mean + SE,
n=3). Even though we observed a degree of variability in the absolute CPM values for
[57Co]Cbl in each of the fractions assessed over three independent experiments (Fig 5B), the
proportional distribution of [57Co]Cbl in the intracellular compartments was remarkably
constant (Fig 5A).

3.6. Subcellular [57Co]cobalamin distribution in lysosomes, mitochondria and cytosol from
brain

In a final series of experiments, we assessed if the subcellular fractionation methods utilized
above could also be applied to study [57Co]Cbl distribution in lysosomes, mitochondria and
cytosol isolated from mouse brain. Two male C57Bl/6J mice were injected intraperitoneally
with 3 Ci [57Co]Cbl. After 72 h the mice were euthanased, perfused with PBS, and the
major organs (listed below) were carefully dissected. The distribution of radioactivity in the
whole organs collected from the two mice was: brain 13,200 – 14,000 cpm, liver 354,000 412,000 cpm, kidney 316,000 – 545,000 cpm, heart 8,100 – 8,500, spleen 11,000 – 14,600
cpm (individual values shown, n=2). The radioactivity in plasma was 117,000 – 128,000 cpm
per 100 l (individual values shown, n=2), and in faeces was 340,000 cpm (total value and
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only collected in one experiment). A total of 32% of the injected [57Co]Cbl radioactivity was
recovered in these samples. The relative ratio of [57Co]Cbl recovered in the whole organs
was: brain 1 : liver 28 : kidney 32 : heart 0.6 : spleen 1.

We then subjected the whole brain to the subcellular fractionation method developed above.
Highly purified lysosomal and mitochondrial preparations that were essentially free of actin were recovered from Fractions 1 to 4 and from Fractions 7 to 9, respectively (Fig. 6A).
Analysis of the mouse brain cytosolic fractions indicated a strong signal for -actin in
Fractions 1 to 5 and no contamination with either LAMP2 or VDAC1 (Fig. 6B). Similar to
the data derived from cultured cells, acid phosphatase activity colocalised predominatly in the
LAMP2-positive fractions (Fig. 6C). Finally, the relative distribution of [57Co]Cbl in the
organelle fractions derived from the brain was measured and found to be: lysosomes 215 (5)
cpm, mitochondria 290 (25) cpm and cytosol 1295 (35) cpm (mean values with range shown
in parentheses). The corresponding relative percentage distribution values were therefore
lysosomes 12%, mitochondria 15%, and cytosol 73% (Fig. 6D).

4. Discussion

In the present work we have successfully developed a [57Co]Cbl metabolic labeling /
subcellular fractionation method that permits the separation of the two major pools of
intracellular Cbl (in the cytosol and mitochondria) from the presumably more transient
lysosomal pool. This methodology builds on many previous studies that have separately
analysed cellular [57Co]Cbl metabolism in cells and mice (Hannibal et al., 2008; Mellman et
al., 1978; Yamani et al., 2008; Yassin et al., 2000; Youngdahl-Turner et al., 1978) or aspects
of lysosome function in cells and mice (Manunta et al., 2007; Yang et al., 2011). Our data
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derived from fibroblast and neuronal cell lines indicates that under steady-state conditions,
only ~6% of cellular [57Co]Cbl resides in the lysosome. This is perhaps not surprising based
on the fact that the major sites of Cbl utilization in humans are the enzymes MS and MMCM
located in the mitochondria and cytosol respectively. We also showed that the subcellular
fractionation methods could be used to assess lysosomal [57Co]Cbl content in mouse brain. In
this case ~12% of cellular [57Co]Cbl was detected in the lysosome and this was similar to the
amount in mitochondria (~15%). It is currently not clear why lysosomes isolated from the
brain are apparently enriched in [57Co]Cbl as compared to the cell lines. We were unable to
measure mouse MS by western blotting so it is possible that traces of cytosolic contamination
in these fractions could contribute to the cpm values; although the very low levels of -actin
contamination would argue against this. Further rinse steps after the OptiPrep gradient (see
Fig 1) may improve organelle purity; however, the challenge with the brain analysis is the
relatively low amount of [57Co]Cbl incorporation and the possibility that further rinsing may
reduce recovery of the lysosomes. In the brain subcellular fractionation experiments, much
more material was loaded onto the OptiPrep gradient (e.g. the lysosomal acid phosphatase
activity is 10-fold higher than for the neuronal cell line (compare Fig. 3B and Fig. 6C) and it
is possible that analysis of a smaller fraction of the brain tissue would alter the recovery of
organelles through the fractions. Again, though, this would reduce the amount of [57Co]Cbl
that could be detected in the fractions. Future studies could adapt the methods we have
established to investigate lysosomal [57Co]Cbl distribution in brain tissues from other species
and in mouse models of ageing and neurodegenerative disease.

We also noted that in the subcellular fractionation of the brain tissue, a small increase in acid
phosphatase activity was present with the major mitochondrial fraction (Fraction 8). We did
not detect LAMP2 in this fraction so lysosomal contamination seems unlikely. One possible
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explanation could be that one or more of the several known mitochondrial phosphatases may
have residual activity at pH 4.8 and thus act upon the 4-NPP is our assay (McBride et al.,
2006).

The critical role that the lysosome plays in delivery of Cbl to MS in the cytosol and MMCM
in the mitochondrion is demonstrated by the inborn error of Cbl metabolism referred to as
cblF. This life-threatening condition is caused by defects in the LMBRD1 gene that encodes
LMBD1 (Rutsch et al., 2009). The defect in lysosomal Cbl release was discovered 25 years
ago, well before the likely transporter involved was characterised (Rosenblatt et al., 1985).
These pioneering studies also showed that chloroquine, a compound that increases lysosomal
pH above its physiological level of ~ 4.5 thereby inhibiting lysosomal protease activity,
prevents the release of Cbl from TCII and blocks the transport of lysosomal [57Co]Cbl to both
MS and MMCM (Rosenblatt et al., 1985). We have recently hypothesized that in addition to
LMBRD1 mutations and drug-mediated alterations of lysosomal function that may trap Cbl in
the lysosome, additional pathophysiological perturbations in lysosome function could also
represent a “roadblock” for Cbl transit through the lysosomal compartment (Zhao et al.,
2011). Future studies could utilize the methods we have established herein to assess cell lines
and animals models that are known to have impaired lysosome function due to, for example,
accumulation of the age pigment lipofuscin, substrate accumulation in various lysosomal
storage diseases, or accumulation of -amyloid (Zhao et al., 2011). Based on the fact that Cbl
deficiency includes a neurological phenotype (Baik and Russell, 1999; Calvaresi and Bryan,
2001; Healton et al., 1991) we focused on brain tissue in the in vivo aspect of the present
study. There is no reason why the techniques could not be employed to study other tissues in
animal studies and we predict (based on the much higher [57Co]Cbl levels recovered in the
liver and kidney, that the injected [57Co]Cbl dose could be reduced at least 10-fold. Finally,
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although we have chosen to use commercially available reagents for some of the subcellular
fractionation steps, it is likely that buffer compositions that have been published (e.g.
(Graham, 2001; Koenig, 1974; Yamada et al., 1984)) may yield similar results.

5. Conclusions
We have established a subcellular fractionation method that provides a useful tool for
investigating intracellular [57Co]Cbl trafficking. The method can be applied to both neuronal
and fibroblast cell lines and in brain tissues and may be adapted to study the impact that
pathophysiological impairment of lysosomal function has on intracellular [57Co]Cbl transport
in vitro and in vivo.
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Figure legends

Fig. 1. Overview of [57Co]Cbl labelling and subcellular fractionation procedures. Cells were
incubated with 0.025 Ci/ml [57Co]cyanoCbl in DMEM with 10% (v/v) human serum at
37˚C for 48 h. The cells were then homogenized in a ball-bearing homogenizer to disrupt the
plasma membrane. Membrane debris and nuclei were removed by centrifugation at 600 g for
10 min and the supernatant samples overlayed at the top of an OpitPrep density gradient.
After ultracentrifugation at 145,000 g for 4 h, a total 10 fractions of 600 μl each were
collected and the lysosomal/mitochondrial fractions separated from the cytosol by mixing
with PBS followed by further centrifugation at 20,000 g for 30 min. The organelle and
cytosol fractions were thereafter assessed for appropriate markers and for [57Co]
radioactivity.

Fig. 2. Separation of lysosomes, mitochondria, and cytosol in HT1080 fibroblast fractions.
Approximately 16 x 106 cells were metabolically labelled with [57Co]Cbl for 48 h. The
radiolabelled cells were disrupted using a ball-bearing homogeniser and the lysosomes,
mitochondria, and cytosol fractions were separated using an OptiPrep gradient. The
appearance of the markers LAMP2 (lysosomal), VDAC1 (mitochondrial), β-actin and MS
(both cytosolic) were then probed by wester blotting in all fractions (note Fraction 1 is the
least dense from the top of the gradient). (A) In the pellet fractions, a clear separation could
be seen for lysosomes (fractions 1 to 5) and mitochondria (fractions 7 to 9). Cytosolic
markers were either absent or present only at trace amounts. (B) In the supernatant portion of
the fractions, lysosomal, mitochondrial markers were not detected, however, strong signals
for cytosolic markers β-actin (fractions 1 to 8) and MS (fractions 1 to 2) were detected. Data
are representative of three independent experiments.
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Fig. 3. Separation of lysosomes, mitochondria, and cytosol in SH-SY5Y neuron fractions.
Approximately 16 x 106 cells were metabolically labelled with [57Co]Cbl for 48 h. The
radiolabelled cells were disrupted using a ball-bearing homogeniser and the lysosomes,
mitochondria, and cytosol fractions were separated using an OptiPrep gradient. The
appearance of the markers LAMP2 (lysosomal), VDAC1 (mitochondrial), β-actin and MS
(both cytosolic) were then probed by wester blotting in all fractions (note fraction 1 is the
least dense from the top of the gradient). (A) In the pellet fractions, a clear separation could
be seen for lysosomes (fractions 1 to 5) and mitochondria (fractions 7 to 9). Cytosolic
markers were absent. (B) In the supernatant portion of the fractions, lysosomal, mitochondrial
markers were not detected, however, strong signals for cytosolic markers β-actin (fractions 1
to 8) and MS (fractions 2 to 5) were detected. Data are representative of three independent
experiments.

Fig. 4. Acid phosphatase activity in HT1080 fibroblast and SH-SY5Y neuron fractions.
Approximately 16 x 106 cells were disrupted and fractionated using an OptiPrep gradient as
described in the Legend to Fig. 2. Acid phosphatase activity (indicating the presence of
lysosomes with an intact membrane) was measured in all pellet fractions (circles) and
cytosolic fractions (squares) using 4-nitrophenyl phosphate (4-NPP) as a colorimetric
substrate. Acid phosphatase activity in HT1080 fibroblast fractions (A) and SH-SY5Y neuron
fractions (B) indicate that lysosomes are predominantly found at the top of the density
gradient (fraction 1) and are structurally intact (high acid phosphatase activity). Acid
phosphatase activity in the supernatant fractions was negligible.
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Fig. 5. Distribution of [57Co]Cbl in lysosomes, mitochondria, and cytosol derived from
HT1080 fibroblasts and SH-SY5Y neurons. Approximately 16 x 106 cells were metabolically
labelled with [57Co]Cbl for 48 h. The radiolabelled cells were disrupted using a ball-bearing
homogeniser and the lysosomes, mitochondria, and cytosol fractions were separated using an
OptiPrep gradient. (A) The proportional distribution of [57Co]Cbl was assessed using a
gamma counter and expressed as a percentage of radioactvoty in each fraction for both cell
types. Data are means with SE represented by the error bars (n=3 experiments for each cell
type). L, lysosome; M, mitochondria; C, cytosol. (B) The cpm data for each of the fractions
in three independent experiments performed for each cell type shown in “A” is provided.

Fig. 6. Isolation and characterisation of lysosomes, mitochondria, and cytosol derived from
mouse brain. A 12-month old male C57Bl/6J mouse was injected intraperitoneally with 3 Ci
[57Co]Cbl and after 72 h the mouse was euthanased, perfused, and the brain was
homogenised using a ball-bearing homogeniser. The lysosomes, mitochondria, and cytosol
fractions were then separated using an OptiPrep gradient. (A) In the pellet fractions, a clear
separation could be seen for lysosomes (fractions 1 to 3) and mitochondria (fractions 6 – 9)
based on LAMP2 and VDAC1 levels, respectively. The cytosolic marker, -actin, was either
absent or present only at trace amounts. (B) In the supernatant portion of the fractions,
lysosomal and mitochondrial markers were not detected, however, a strong signal for
cytosolic marker β-actin (fractions 1 to 5) was detected. (C) Acid phosphatase activity
(indicating the presence of lysosomes with an intact membrane) was measured in all pellet
fractions (circles) and cytosolic fractions (squares) using 4-nitrophenyl phosphate (4-NPP) as
a colorimetric substrate. Acid phosphatase activity indicates that lysosomes are
predominantly found at the top of the density gradient (fraction 1) and are structurally intact
(high acid phosphatase activity). Acid phosphatase activity in the supernatant fractions was
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negligible. (D) The proportional distribution of [57Co]Cbl was assessed using a gamma
counter and expressed as a percentage of radioactivity in each fraction. L, lysosome; M,
mitochondria; C, cytosol. Data are representative of two similar experiments.
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Table 1: OptiPrep density gradient preparation
OptiPrep medium

Gradient dilution buffer

Final volume

OptiPrep final

volume (µl)

volume (µl)

(µl)

concentration (%)

283.3

716.7

1000

17

333.3

666.7

1000

20

191.7

308.3

500

23

450

550

1000

27

500

500

1000

30
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